Filing Details
- Accession Number:
- 0001883850-22-000031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-01 16:08:16
- Reporting Period:
- 2022-03-30
- Accepted Time:
- 2022-04-01 16:08:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1013064 | Roy P Vagelos | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-03-30 | 14,286 | $700.02 | 127,006 | No | 4 | S | Indirect | by CLAT |
| Common Stock | Disposition | 2022-03-30 | 14,286 | $700.00 | 23,461 | No | 4 | S | Indirect | by Spouse as Trustee |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | by CLAT |
| No | 4 | S | Indirect | by Spouse as Trustee |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 345,566 | Direct | |
| Common Stock | 2,096 | Indirect | By 401(k) Plan |
| Common Stock | 3,609 | Indirect | by trust for grandch |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 14,286 shares of Company stock on March 30, 2022 at prices ranging from $700.00 to $700.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 30, 2022 at each separate price.
- Represents volume-weighted average price of sales of 14,286 shares of Company stock on March 30, 2022 at prices ranging from $700.00 to $700.05. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 30, 2022 at each separate price.
- By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.
Billionaire Hedge Funds
